Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
7(87.5%)
Phase 3
1(12.5%)
8Total
N/A(7)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT05306184Active Not Recruiting

Prospective Assessment of Cost-effectiveness and Side-effects of Depressive Patients Treated With ECT or TCA

Role: collaborator

NCT05331937Phase 3Recruiting

TMS for Exposure Therapy Resistant OCD

Role: collaborator

NCT06298695Not ApplicableNot Yet Recruiting

Schema Therapy for Treatment-resistant Anxiety Disorders

Role: collaborator

NCT03929081Not ApplicableCompleted

Alternative Treatment to Reduce Chronicity in OCD: Research Into Brain Response and Adequacy of Treatment

Role: collaborator

NCT01604876Not ApplicableCompleted

Effect of Bright Light on Mood and Sleep in Parkinson's Disease

Role: collaborator

NCT03652883Not ApplicableCompleted

ImpleMentAll - Towards Evidence-based Tailored Implementation Strategies for eHealth

Role: collaborator

NCT02389660Not ApplicableCompleted

European Comparative Effectiveness Research on Internet-based Depression Treatment in Poland

Role: collaborator

NCT02525367Not ApplicableTerminated

Online Cognitive Training in PD, MS and Depressed Patients Treated With Electroconvulsive Therapy

Role: collaborator

NCT03217955Not ApplicableCompleted

Cognitive Behavioural Therapy- Social Functioning In Adolescence With Recent Onset Schizophrenia

Role: collaborator

All 9 trials loaded